These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Site-specific associations between miRNA expression and survival in colorectal cancer cases. Slattery ML; Herrick JS; Pellatt DF; Mullany LE; Stevens JR; Wolff E; Hoffman MD; Wolff RK; Samowitz W Oncotarget; 2016 Sep; 7(37):60193-60205. PubMed ID: 27517623 [TBL] [Abstract][Full Text] [Related]
4. MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Slattery ML; Wolff E; Hoffman MD; Pellatt DF; Milash B; Wolff RK Genes Chromosomes Cancer; 2011 Mar; 50(3):196-206. PubMed ID: 21213373 [TBL] [Abstract][Full Text] [Related]
5. Alterations in microRNA expression associated with alcohol consumption in rectal cancer subjects. Mullany LE; Herrick JS; Wolff RK; Stevens JR; Slattery ML Cancer Causes Control; 2017 Jun; 28(6):545-555. PubMed ID: 28303484 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-transcription factor interactions and their combined effect on target gene expression in colon cancer cases. Mullany LE; Herrick JS; Wolff RK; Stevens JR; Samowitz W; Slattery ML Genes Chromosomes Cancer; 2018 Apr; 57(4):192-202. PubMed ID: 29226599 [TBL] [Abstract][Full Text] [Related]
7. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer. Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750 [TBL] [Abstract][Full Text] [Related]
8. Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study. Mullany LE; Herrick JS; Wolff RK; Buas MF; Slattery ML BMC Med Genomics; 2016 Apr; 9(1):21. PubMed ID: 27107574 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding. Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773 [TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival. Mullany LE; Herrick JS; Wolff RK; Slattery ML Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935 [TBL] [Abstract][Full Text] [Related]
11. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol. Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696 [TBL] [Abstract][Full Text] [Related]
12. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082 [TBL] [Abstract][Full Text] [Related]
13. Identification of aberrantly expressed miRNAs in rectal cancer. Li X; Zhang G; Luo F; Ruan J; Huang D; Feng D; Xiao D; Zeng Z; Chen X; Wu W Oncol Rep; 2012 Jul; 28(1):77-84. PubMed ID: 22576798 [TBL] [Abstract][Full Text] [Related]
14. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
15. The TGFβ-signaling pathway and colorectal cancer: associations between dysregulated genes and miRNAs. Pellatt AJ; Mullany LE; Herrick JS; Sakoda LC; Wolff RK; Samowitz WS; Slattery ML J Transl Med; 2018 Jul; 16(1):191. PubMed ID: 29986714 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analyses of microRNA and mRNA expression in colorectal serrated lesions and colorectal cancer with a microsatellite instability phenotype. Sugai T; Osakabe M; Niinuma T; Eizuka M; Tanaka Y; Yamada S; Yanagawa N; Otsuka K; Sasaki A; Matsumoto T; Suzuki H Genes Chromosomes Cancer; 2022 Mar; 61(3):161-171. PubMed ID: 34846081 [TBL] [Abstract][Full Text] [Related]
17. Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Slattery ML; Edwards S; Curtin K; Schaffer D; Neuhausen S Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):882-9. PubMed ID: 14504199 [TBL] [Abstract][Full Text] [Related]
18. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]